COPD study for Brazilian patients
Part of Lungs & breathing clinical trials.
This study looks at the health of Brazilian adults with COPD. It aims to understand how the condition affects people and may help improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older
- You must have a confirmed COPD diagnosis based on recent guidelines or symptoms
- You may qualify if you’ve had a COPD flare-up that required a hospital stay or medication change
- You may also qualify if your lung function is below a certain level
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with severe or very severe COPD to learn more about their health over time. You may qualify if your COPD causes many symptoms or frequent flare-ups.
This study looks at how well a triple inhaler (BDP/FF/GB) works for people with severe COPD in Brazil. It may help those who have had at least one flare-up in the past year.
This trial looks at how heart failure with preserved pumping function affects people who also have COPD. It aims to understand the course of the disease and long-term outlook.
This trial looks at how long-term health conditions like heart disease, diabetes, or high blood pressure might affect breathing problems. The goal is to better understand and help people with both issues.
This study looks at how chronic lung disease relates to other health conditions in people receiving care at primary health clinics in Brazil. It will test a new approach to identify and help patients with multiple health problems.
This study is looking for people living in Portugal to find out how many have COPD (a lung condition). You will do a simple breathing test to check your lung health.
Hear when a new COPD (Chronic Obstructive Pulmonary Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.